Astrocytoma, IDH-Wildtype — Trials

Astrocytoma, IDH-Wildtype — Trials · CancerIndex

Clinical trials

Registered studies

3 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04729959	Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma	active not recruiting	Phase 2	61	National Cancer Institute (NCI)NIH	1	Sep 23, 2026	clinicaltrials
NCT04623931	Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas	recruiting	Phase 2	40	M.D. Anderson Cancer CenterOTHER	1	Jul 16, 2026	clinicaltrials

Data updated 5 days agoSource updated Sep 23, 2026source: clinicaltrials